BlackRock Investment Management, LLC - ASTERIAS BIOTHERAPEUTICS INC ownership

ASTERIAS BIOTHERAPEUTICS INC's ticker is AST and the CUSIP is 04624N107. A total of 66 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of ASTERIAS BIOTHERAPEUTICS INC
ValueSharesWeighting
Q4 2016$382,000
+9.5%
82,955
+0.8%
0.00%
Q3 2016$349,000
+98.3%
82,269
+12.2%
0.00%
Q2 2016$176,000
+2.3%
73,307
+100.7%
0.00%
Q1 2016$172,000
+22.9%
36,525
+2.2%
0.00%
Q4 2015$140,000
+1.4%
35,7500.0%0.00%
Q3 2015$138,000
-17.4%
35,750
-1.8%
0.00%
Q2 2015$167,00036,3980.00%
Other shareholders
ASTERIAS BIOTHERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 3,699,848$15,687,0002.68%
Northeast Financial Consultants Inc 732,265$3,105,0001.31%
WEDBUSH SECURITIES INC 15,000$64,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 148,054$628,0000.01%
THRIVENT FINANCIAL FOR LUTHERANS 413,278$1,752,0000.01%
Virtu KCG Holdings LLC 72,989$309,0000.01%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 35,555$151,0000.00%
WILLIAMS JONES & ASSOCIATES LLC 15,100$64,0000.00%
BlackRock Fund Advisors 612,231$2,596,0000.00%
Spot Trading L.L.C 15,000$64,0000.00%
View complete list of ASTERIAS BIOTHERAPEUTICS INC shareholders